Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.370
-0.160 (-6.32%)
At close: May 8, 2026, 4:00 PM EDT
2.340
-0.030 (-1.27%)
After-hours: May 8, 2026, 7:22 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $304.96 million as of May 8, 2026. Its market cap has decreased by -46.92% in one year.
Market Cap
304.96M
Enterprise Value
284.44M
1-Year Change
-46.92%
Ranking
Category
Stock Price
$2.37
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $304.96M, a decrease of -75.33%. That is a compound annual growth rate of -17.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 304.88M | -53.62% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquestive Therapeutics | 525.72M |
| Kamada | 489.14M |
| Emergent BioSolutions | 471.07M |
| Canopy Growth | 444.50M |
| Evolus | 420.81M |
| SIGA Technologies | 339.25M |
| Akebia Therapeutics | 316.54M |
| Alpha Teknova | 214.44M |